Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19

Abstract SARS-CoV-2 infection has a risk to develop into life-threatening COVID-19 disease. Whereas age, hypertension, and chronic inflammatory conditions are risk factors, underlying host factors and markers for disease severity, e.g. requiring intensive care unit (ICU) treatment, remain poorly def...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liis Haljasmägi, Ahto Salumets, Anna Pauliina Rumm, Meeri Jürgenson, Ekaterina Krassohhina, Anu Remm, Hanna Sein, Lauri Kareinen, Olli Vapalahti, Tarja Sironen, Hedi Peterson, Lili Milani, Anu Tamm, Adrian Hayday, Kai Kisand, Pärt Peterson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/122d14a3063c481cb0cc3d33b02d79ac
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:122d14a3063c481cb0cc3d33b02d79ac
record_format dspace
spelling oai:doaj.org-article:122d14a3063c481cb0cc3d33b02d79ac2021-12-02T15:09:57ZLongitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-1910.1038/s41598-020-77525-w2045-2322https://doaj.org/article/122d14a3063c481cb0cc3d33b02d79ac2020-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-77525-whttps://doaj.org/toc/2045-2322Abstract SARS-CoV-2 infection has a risk to develop into life-threatening COVID-19 disease. Whereas age, hypertension, and chronic inflammatory conditions are risk factors, underlying host factors and markers for disease severity, e.g. requiring intensive care unit (ICU) treatment, remain poorly defined. To this end, we longitudinally profiled blood inflammation markers, antibodies, and 101 plasma proteins of hospitalized COVID-19 patients who did or did not require ICU admission. While essentially all patients displayed SARS-CoV-2-specific antibodies and virus-neutralization capacity within 12–15 days, a rapid, mostly transient upregulation of selective inflammatory markers including IL-6, CXCL10, CXCL11, IFNγ, IL-10, and monocyte-attracting CCL2, CCL7 and CCL8, was particularly evident in ICU patients. In addition, there was consistent and sustained upregulation of apoptosis-associated proteins CASP8, TNFSF14, HGF, and TGFB1, with HGF discriminating between ICU and non-ICU cohorts. Thus, COVID-19 is associated with a selective inflammatory milieu within which the apoptotic pathway is a cardinal feature with potential to aid risk-based patient stratification.Liis HaljasmägiAhto SalumetsAnna Pauliina RummMeeri JürgensonEkaterina KrassohhinaAnu RemmHanna SeinLauri KareinenOlli VapalahtiTarja SironenHedi PetersonLili MilaniAnu TammAdrian HaydayKai KisandPärt PetersonNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Liis Haljasmägi
Ahto Salumets
Anna Pauliina Rumm
Meeri Jürgenson
Ekaterina Krassohhina
Anu Remm
Hanna Sein
Lauri Kareinen
Olli Vapalahti
Tarja Sironen
Hedi Peterson
Lili Milani
Anu Tamm
Adrian Hayday
Kai Kisand
Pärt Peterson
Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
description Abstract SARS-CoV-2 infection has a risk to develop into life-threatening COVID-19 disease. Whereas age, hypertension, and chronic inflammatory conditions are risk factors, underlying host factors and markers for disease severity, e.g. requiring intensive care unit (ICU) treatment, remain poorly defined. To this end, we longitudinally profiled blood inflammation markers, antibodies, and 101 plasma proteins of hospitalized COVID-19 patients who did or did not require ICU admission. While essentially all patients displayed SARS-CoV-2-specific antibodies and virus-neutralization capacity within 12–15 days, a rapid, mostly transient upregulation of selective inflammatory markers including IL-6, CXCL10, CXCL11, IFNγ, IL-10, and monocyte-attracting CCL2, CCL7 and CCL8, was particularly evident in ICU patients. In addition, there was consistent and sustained upregulation of apoptosis-associated proteins CASP8, TNFSF14, HGF, and TGFB1, with HGF discriminating between ICU and non-ICU cohorts. Thus, COVID-19 is associated with a selective inflammatory milieu within which the apoptotic pathway is a cardinal feature with potential to aid risk-based patient stratification.
format article
author Liis Haljasmägi
Ahto Salumets
Anna Pauliina Rumm
Meeri Jürgenson
Ekaterina Krassohhina
Anu Remm
Hanna Sein
Lauri Kareinen
Olli Vapalahti
Tarja Sironen
Hedi Peterson
Lili Milani
Anu Tamm
Adrian Hayday
Kai Kisand
Pärt Peterson
author_facet Liis Haljasmägi
Ahto Salumets
Anna Pauliina Rumm
Meeri Jürgenson
Ekaterina Krassohhina
Anu Remm
Hanna Sein
Lauri Kareinen
Olli Vapalahti
Tarja Sironen
Hedi Peterson
Lili Milani
Anu Tamm
Adrian Hayday
Kai Kisand
Pärt Peterson
author_sort Liis Haljasmägi
title Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
title_short Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
title_full Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
title_fullStr Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
title_full_unstemmed Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19
title_sort longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe covid-19
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/122d14a3063c481cb0cc3d33b02d79ac
work_keys_str_mv AT liishaljasmagi longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT ahtosalumets longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT annapauliinarumm longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT meerijurgenson longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT ekaterinakrassohhina longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT anuremm longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT hannasein longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT laurikareinen longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT ollivapalahti longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT tarjasironen longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT hedipeterson longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT lilimilani longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT anutamm longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT adrianhayday longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT kaikisand longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
AT partpeterson longitudinalproteomicprofilingrevealsincreasedearlyinflammationandsustainedapoptosisproteinsinseverecovid19
_version_ 1718387735139450880